Animal models are critical to the advancement of our knowledge of infectious disease pathogenesis, diagnostics, therapeutics, and prevention strategies. The use of animal models requires thoughtful consideration for their well-being, as infections can significantly impact the general health of an animal and impair their welfare. Application of the 3Rsreplacement, refinement, and reduction-to animal models using biohazardous agents can improve the scientific merit and animal welfare. Replacement of animal models can use in vitro techniques such as cell culture systems, mathematical models, and engineered tissues or invertebrate animal hosts such as amoeba, worms, fruit flies, and cockroaches. Refinements can use a variety of techniques to more closely monitor the course of disease. These include the use of biomarkers, body temperature, behavioral observations, and clinical scoring systems. Reduction is possible using advanced technologies such as in vivo telemetry and imaging, allowing longitudinal assessment of animals during the course of disease. While there is no single method to universally replace, refine, or reduce animal models, the alternatives and techniques discussed are broadly applicable and they should be considered when infectious disease animal models are developed.
biocontainment research facilities with animal holding capabilities, including two designated National Biocontainment Laboratories and 12 Regional Biocontainment Laboratories to facilitate research on biodefense and emerging infectious diseases. 1 Research into these agents has steadily increased over the past 16 years and does not appear to be decelerating as emerging agents, antimicrobial resistance, and bioterrorism continue to be threats (Figure 1 ).
Animal use in biohazard studies requires careful consideration of the well-being of the animals involved, as their health will undoubtedly be compromised, resulting in potential pain or distress. It is incumbent upon the investigators and Institutional Animal Care and Use Committees to properly address animal welfare concerns and consider the 3Rs established by Russell and Burch. 2 The 3Rs outlined in The Principles of Humane Experimental Technique are replacement, reduction, and refinement. The aim of these tenets is to improve the treatment of research animals while advancing science. 3 They are based on the belief that humane treatment of animals is required for sound science, as experiments conducted with animals that experience the least possible distress produce better scientific results. 3, 4 Applying the 3Rs to infectious disease studies (synonymous with biohazards for our purposes) can be very challenging given that infection will usually result in distress in the animals as clinical disease develops; however, the longterm benefit to human and animal health can be tremendous. Therefore, we are ethically obligated to apply the principles of the 3Rs to minimize the impact the infectious agent may have on the well-being of the research animals.
Both the Animal Welfare Act and the Public Health Service Policy on the Humane Care and Use of Laboratory Animals state that the Institutional Animal Care and Use Committees must consider alternatives to painful and distressful procedures. 5, 6 The 3Rs are often used as a basis to identify alternatives. Although not entirely in alignment with Russell and Burch's definition of the 3Rs, 3, 4 the Guide for the Care and Use of Laboratory Animals (the Guide) defines the 3Rs as follows: "Replacement refers to methods that avoid using animals. The term includes absolute replacements (ie, replacing animals with inanimate systems such as computer programs) as well as relative replacements (ie, replacing animals such as vertebrates with animals that are lower on the phylogenetic scale). Refinement refers to modifications of husbandry or experimental procedures to enhance animal well-being and minimize or eliminate pain and distress. Reduction involves strategies for obtaining comparable levels of information from the use of fewer animals or for maximizing the information obtained from a given number of animals (without increasing pain or distress) so that in the long run fewer animals are needed to acquire the same scientific information." 7 
Replacement
Perhaps the most challenging application of the 3Rs in infectious disease studies is replacement. Many aspects of the disease processes cannot be fully mimicked without a whole-body response. Nonetheless, there are examples of absolute and relative replacements in infectious disease studies. The examples below show the promise these replacements bring to understanding organismal biology, disease pathogenesis, and propelling drug discovery forward.
In Vitro, Mathematical, and Computer Models
In vitro approaches such as cell cultures, organoids, organs-ona chip, 3D printed tissues (additive manufacturing), and mathematical and computer modeling expand our ability to study biohazardous agents while minimizing the use of animals. In vitro studies facilitate exploration of cellular, molecular, and genomic mechanisms of disease. They also support investigation of potential therapeutic agents. Since animal models may not adequately replicate responses or pathogenesis of human disease, these approaches play a complimentary role. 8 Garira recently performed an extensive review of multiscale models of infectious disease systems. 9 This review describes the use of a systems approach to categorize infectious disease information into a series of scales based on host, pathogen, environment, and health intervention. Once completed, these multiscale models will pave the way for new alternative applications with increased predictive value for these complex systems.
Citing the lack of suitable animal models, the need for better predictors of human immune responses, and the multitude of pathogens that grow poorly outside the human host, all of which hamper the ability to study infectious agents, genetically modify them, or develop appropriate therapies, Mills and Estes hypothesized that advances in tissue engineering and increased Figure 1 . Publications resulting from a PubMed search using the search terms "animal" and "model" and "infectious disease" from 1999 to 2016. scientific collaboration provide pathways to overcoming these barriers. 10 They describe a variety of in vitro models from different organs useful for studying disease pathogenesis. There have been several recent reviews of in vitro models of infectious diseases, particularly engineered approaches. [11] [12] [13] [14] [15] [16] [17] [18] [19] Engineered tissue models range from relatively simple systems with an airliquid interface with one to two cell types to more complex systems mimicking tissue and organ functionality. 13, 14, 19 In vitro approaches allow for more control and manipulation than possible in whole animal systems. Use of pluripotent stem cells capable of self-regeneration greatly magnifies the capabilities of these systems. 12 While these systems are enormously useful, there are some limitations to their effectiveness: 13, 14 they are not appropriate for long-term studies and they do not contain all the systems in a living organism. Nevertheless, in vitro systems facilitate standardization, a higher throughput, may be less expensive, are more humane, and may allow better understanding of disease progression at the molecular level. 19, 20 Cell Culture Cell culture systems have played a key role in understanding the pathogenesis of infectious diseases and development of therapeutic agents against those organisms. Such systems have typically involved a single layer of cells in a culture dish although microcapillaries have been used as well. 11, 21 Both primary cells and cell lines are employed in studying infectious agents. Cancer cell lines have helped elucidate the mechanism of action of anthrax toxins such as lethal toxin, toxin capillary morphogenesis gene-2, and Tumor Endothelial Marker 8. [22] [23] [24] [25] [26] The fundamental steps in the pathogenesis of inhalational anthrax including cellular spore uptake, germination conditions, cellular translocation of spores, and antimicrobial efficacy have been demonstrated using this approach. 21, [27] [28] [29] [30] New virulence factors for Yersinia pestis, which could serve as potential vaccine candidates, have been developed using the RAW 264.7 murine macrophage cell line. 31 Several model systems exist for studying tuberculosis in vivo and in vitro. 11, 32, 33 Cultured macrophages have been used in Mycobacterium tuberculosis studies of pathogenesis and disease progression, escape from phagolysosomes, intracellular multiplication, and gene expression. [34] [35] [36] [37] Cell culture systems are critical for rapid screening of new drugs and speeding translation in vivo. 38 Although much progress has been made with in vitro models, it is important to acknowledge the differences in performance between in vitro and in vivo systems; generally, in vitro models are not complete replacements for animal models. 30, 39 Engineered Tissues and 3D Models A major advance in the cell culture models has been the development of engineered tissues and 3D models, some of which can be printed onto a matrix and used for drug development and disease progression. 19, 40, 41 Various approaches and the future of tissue engineering with applications to viral infections have been reviewed. 42 In vitro models using intestinal cells for studying host-microbe interactions, including co-culture approaches, tissue explants, bio-reactors constituting and modulating physiological conditions, organoids developed from pluripotent stem cells, and 3D matrices that allow self-assemblage and differentiation into apical lumens and basal environments, have been described. 43 There are different model systems for studying tuberculosis, and a synopsis of the scientific potential, limitations, costs, infrastructure requirements and skills needed was recently reviewed. 44 3D organoid models provide a unique means of investigating this devastating disease. A human lung model consisting of lung-derived cell lines and peripheral blood macrophages reportedly displays characteristics of lung tissue, including stratified epithelium, extracellular matrix, and mucus secretion. Infection of this tissue model with M. tuberculosis results in formation of what resembles early tuberculosis granuloma. 33 A 3D tissue-specific model consisting of epithelial cells and fibroblasts cultured on a collagen matrix on top of a porous matrix using organotypic culture methods is reputed to stratify and secrete matrix at the air interface. 45 Using primary human macrophages infected with M. tuberculosis, migration of immune cells and development of granulomas occurred.
Organotypic cultures of human lung slices have been used to study anthrax spore movement between antigen presenting cells and alveolar epithelial cells, and the influence of anthrax toxin on the process. 27 Entry of spores into the lung is a critical step in the development of the disease, and this approach provides a reproducible way to understand the mechanism. A 3D model of human airway tissues grown on a collagen/fibronectin gel support at an air-liquid interface mimicking in vivo situation has been developed. 46 The system models anthrax inhalation and permits understanding of the role of the constituent cells.
Mathematical Models
Mathematical models can elucidate the behavior of infectious agents under different conditions and are particularly useful in epidemiological studies. This approach has been used to effectively forecast spread and control of several infectious diseases. [47] [48] [49] [50] [51] Using hierarchical Bayesian and multilevel mathematical models to incorporate information on disease dynamics of host phylogeny, Banerjee determined that smaller passerine birds are more competent at spreading the disease caused by West Nile Virus compared with larger nonpasserine species. 52 Li used mathematical modelling to develop an in vitro assay to quantify neutralizing activity against anthrax lethal toxin. The assay is valid for human, rhesus, and rabbit sera. It is crucial in the quantification of anthrax lethal toxin, assessment of anthrax vaccines, and avoids the use of animals. 53 In Silico Approaches Computer modeling plays a critical role in studying infectious diseases and in the development of new therapies. A computational design for a protein that could be used as a potential therapy for anthrax has been developed. 54 In this study, the Bacillus anthracis poly-γ-D-glutamic acid capsule was targeted by modifying CapD, a B. anthracis γ-glutamyl transpeptidase. By making circular permutations to CapD using computational protein engineering via a Rossetta software suite, 55,56 the quality and production of the enzyme was improved. The role of CapD was further explored using a Gauss View 5 graphical user interface and to identify the rate-limiting steps of CapD catalysis and inhibition. 57, 58 Other approaches to understanding new lead compounds to treat this disease have been proposed using computational methods. 49, [59] [60] [61] Caenorhabditis elegans, wax moths, fruit flies, and cockroaches ( Figure 2 ). These models may be desirable because of their ease in cultivation, low maintenance costs, minimal space requirements, and minimal ethical concerns. 62 Several studies using these species involve innate immune responses, which have been demonstrated to be similar to the mammalian innate immune response. 63 The protozoa, Dictyostelium discoideum, can be genetically modified and shares many cellular defense mechanisms present in mammals, particularly related to phagocytosis. Bacterial virulence factors required for survival in mammalian hosts also permit survival in D. discoideum. 64 D. discoideum has been used as a model for Legionella pneumophila, Mycobacteria sp., Klebsiella pneumonia, Yersinia pseudotuberculosis, Pseudomonas sp., and others. Studies with D. discoideum have provided insight into how L. pneumophila evade the host immune response permitting bacterial replication. Mycobacterial studies with D. discoideum have provided insight on intracellular survival and cellular spread. Nramp1 mutants of D. discoideum negatively affect Mycobacterial growth, similar to Nramp1 in mice. 64 C. elegans has been used to evaluate virulence of Salmonella enterica serovar Typhimurium and response to therapy. 65 C. elegans mutants are readily available and when combined with bacterial mutants enable investigators to study a specific host response to a virulence factor. 66 Galleria mellonella, the greater wax moth, has been used to study the virulence of several pathogens including Burkholderia cepacia complex, 67 Pseudomonas sp., 68 and Streptoccous sp. 69 In addition to possessing an innate immune response similar to mammals, G. mellonella experiments can be performed at 37°C, which is the body temperature of the natural hosts. 69 This is in contrast to Drosophila, which is typically reared at 25°C. 70 Studies using Streptococcus suis-infected G. mellonella larvae demonstrated similar virulence compared with the pig model, and the infection model initiated the larvae's innate immune response. This model was also used to assess the response to antibiotic therapy, and antibiotic treatment following inoculation resulted in larval survival. 69 Fruit flies (Drosophila melanogaster) have been shown to be beneficial to study the virulence and innate immune response to a number of pathogens, including Burkholderia sp., 71 Pseudomonas aeruginosa, 72 S. enterica serovar Typhimurium, 73 and Cryptococcus neoformans. 74 Studies involving Pseudomonasinfected Drosophila were able to identify bacterial mutants with reduced virulence. 72 This model could be used for highthroughput screening of bacterial isolates. Further, the authors were able to identify defects in the Drosophila immune response through genetic mutations that revealed insight into the host immune response to Pseudomonas infections.
The Madagascar hissing cockroach (Gromphadorhina laevigata) has been used as a model to study virulence determinants and immune responses to Burkholderia species. 75 The authors found that the relative virulence of several mutant strains of Burkholderia pseudomallei, B. mallei, and B. thailandensis was comparable to the virulence in a Syrian hamster model. They also reported high numbers of B. pseudomallei in the cytoplasm of the hemocyte, a component of the insect innate immune response, with multinucleated giant cell formation, providing potential mechanisms for immune evasion. While these replacements of higher animals have limitations, they can be used as an important model for subsequent studies in higher hosts.
Refinement
Refinements to experimental procedures should be used to improve the well-being of animals in infectious disease studies. Many of these refinements take advantage of emerging technologies that allow investigators to identify disease progression in a longitudinal manner. These assessments can help identify humane end points precluding prolonged distress in the animal model. The Guide defines humane end points as "the point at which pain or distress in an experimental animal is prevented, terminated, or relieved." 7 The ability to identify an animal experiencing clinical signs early in the course of disease, and as it is progressing, is crucial to determining a more humane end point during experimentation that avoids unnecessary pain and distress. 76 By determining an earlier end point, we are able to reduce or even avoid unnecessary pain or distress that animals may experience when infected with viral, bacterial, or fungal agents and still obtain the results needed for the experimental design. The refinements discussed can be variable depending on the animal models, agent, route of infection, and housing conditions; a one-size-fits-all approach is unlikely to be effective. 77 
Biomarkers
There are a number of biological mediators released by the body in response to infections that could serve as potential biomarkers for infectious disease models. Cytokine perturbations are frequent during infectious disease progression. In a nonhuman primate model of simian immunodeficiency virus, cytokines and chemokines were measured following infection and a differential expression of various cytokines was identified between progressive and nonprogressive infections. 78 While the aim of this study did not involve these measurements for end point determination, these findings highlight the concept of using biological mediators such as cytokines to assess disease progression. These changes will likely be specific to the agent and the model and will need to be developed on a caseby-case basis.
Acute phase proteins, which are nonexistent or minimally present in the blood of healthy animals, 79 are produced in response to a variety of stimuli including trauma, infection, stress, neoplasia, and inflammation and may provide an objective marker for humane end points in infectious disease models. 80 Examples of common acute phase proteins include C-reactive proteins, serum amyloid A, haptoglobin, α2-macroglobulin, and others. 79, 80 In a nonhuman primate model of Bordetella bronchiseptica, C-reactive proteins were 54 to 96 times the baseline values, suggesting that longitudinal monitoring of C-reactive protein could provide a means of studying disease progression. 81 Serum chemistry and enzyme activity may also be used as biomarkers. Lactate dehydrogenase (LD) and isozyme levels have been used as diagnostic and prognostic tools for numerous human diseases, including liver disease, 82 myocardial infarction, 83 hematological disease, 84 and malignancies such as lymphoma and leukemia. 85, 86 Studies in human infections of tuberculosis have demonstrated that LD may be elevated in the serum and pleural fluid of infected individuals. Moreover, some studies have shown that tuberculosis-infected humans have altered serum LD isozyme profiles, particularly an elevated fraction of LD-3. 87, 88 Guinea pigs similarly express all 5 LD isozymes. Lactate dehydrogenase isozymes from guinea pigs prior to inoculation with M. tuberculosis and 4 weeks postinoculation were evaluated. 89 Guinea pigs infected with M. tuberculosis had elevated LD-5 and attenuated LD-1 (Figure 3 ), suggesting a correlation between disease advancement and serum LD isozymes and the potential for the future development and use of isozymes as a biomarker for tuberculosis disease progression. 89 
Temperature and Thermography
Body temperature is an objective measurement that has been used in experiments to determine end stages of disease. 90, 91 An elevated body temperature can indicate a systemic defense mechanism in response to an infection and is associated with behavioral changes such as lethargy, anorexia, and reduced grooming that can be assessed during the course of disease. 92 A drop in body temperature below a certain point can indicate imminent death. 79, 90, 93 Using mice as an example, the normal body temperature in a mouse ranges from 37.0°C to 37.2°C (98.8°F-99.3°F), and a decrease of more than 4.0°C to 6.0°C correlates to impending death after multiple types of immune system challenges, including snake venom and fungal inoculations. 90, 91 However, this is not always the case, as recovery has been reported even after temperatures dropped to below 28.0°C. 94 Efficiently and effectively measuring the body temperature of rodents often proves to be a difficult task and depending on how much stress the animal endures during this process, it may lead to a falsely increased temperature. Thermistor probes, surface temperature probes, and implantable transponders, some of which require frequent handling of the animals, have all been used to measure temperature. Infrared cameras have been used more recently as a noninvasive means to determine body temperature in animals. To demonstrate the utility of thermography in assessing body temperature, 3 mice were intranasally inoculated with B. pseudomallei and body temperature was recorded from transponders and thermography. 95 Thermography assessed in 3 different regions of the body-eye, ear, and flank-correlated with body temperature acquired by transponder during the 3 days postinfection ( Figure 7 ). Regardless of the means of acquiring temperature, baseline measurements are critical for any temperature monitoring to be successful. This is demonstrated in the following example using body temperature as a means to monitor Francisella tularensis infection in mice. 96 In this study, mice were implanted with temperature transponders and inoculated intradermally with 4 different strains of F. tularensis. Temperatures recorded every 1 to 2 hours postinoculation revealed 3 distinct phases: normal, febrile, and hypothermic. The authors found a correlation between the time of death and change in temperature between the phases. They also identified an individual "drop point" (an end point for death based on temperature) for each mouse based on the first temperature after the febrile phase to fall below the mean normal phase and determined the frequency of temperature monitoring to be no less than every 6 hours for their model. While the temperature patterns were similar for all mice, the length of each phase varied based on the bacterial strain; the time to reach a certain phase was also variable. This example demonstrates the ability of temperature monitoring to determine humane end points. However, it also serves as a reminder of the complexity of infectious disease experiments in which factors such as bacterial strain can impact the utility of a previously used end point. Therefore, it is important to continuously assess the chosen end point information to determine if adjustments are necessary.
Clinical Signs and Score Sheets
The use of score sheets to guide animal observations and record animal conditions as a means of identifying appropriate humane end points is not novel 97 but is an important concept of refinement. 3 It is particularly useful in infectious disease research where animals may experience pain or distress during the course of disease. Score sheets not only assist in minimizing the duration of pain or distress but also may reduce the number of animals used in study as intervention via euthanasia allows greater opportunities for sample collection and yields more clinical and research data over death. Scoring systems should provide clear and concise information that highlights the clinical signs of particular relevance, which in turn increases reproducibility. Retrospective analysis of score sheets from completed experiments permits modification of future score sheets to identify the earliest possible clinical signs as surrogate markers for death. 98 Score sheets should be dynamic documents, refined based on new observations during the course of the experiments. Score sheets must be adapted for different species, different experimental agents, and other variables that can occur from experiment to experiment. Therefore, there is no universal score sheet, but there are points to consider in the overall design.
Score sheets must focus observers on clinical signs that are unambiguous and have the most influence on animal welfare. The design starts with information about the species and agent or disease process in the study. Ideally, the design should occur in conjunction with protocol and endpoint development. The score sheet must clearly indicate the monitoring schedule, the anticipated clinical signs, and the end points incorporated in the protocol in a manner that facilitates its use by all observers.
The use of score sheets is particularly important for pilot studies if the research staff has limited or no experience with the test agent and no descriptions are available in the literature. The goal of the pilot study is to determine the time course and behavior of the animals after exposure to the agent or induction of disease process. This may require death as an end point to identify surrogate markers predicting death. The observations during pilot studies must be frequent and occur during the light and dark cycles. Four times a day monitoring (every 6 hours) is a suitable starting point for observations for those studies with an unknown outcome. An example pilot observation sheet is provided in Figure 4 .
Depending on the overall goals of the project, pilot studies conducted as an LD50 study may be appropriate, especially if recovery after significant illness is expected. 99 It is critical for the research staff to understand that the point of the study is to identify surrogate markers for death. Administering a dose greater than the LD50 will likely result in a rapid death, which might make it difficult to determine what clinical signs or combination of clinical signs predict death. Small numbers of animals, for example 10, for these types of study are usually sufficient as long as an appropriate dose is used.
Once pilot data or literature information determines which clinical signs are predictive, then extraneous clinical signs can be excluded from the scoring, and the predictive clinical signs can be used in the pivotal study. For example, the authors (Dohm) performed a pilot study in preparation for a mouse influenza projective that identified the predictive clinical signs and monitoring frequency that enabled euthanasia 24 to 36 hours before death ( Figure 5 ). Using this score sheet, the investigator was able to collect viral and experimental vaccine titers from nearly every animal, which was not previously possible.
Interpretation of clinical signs is critical and can be variable. For example, "difficult breathing" may seem explicit; however, different observers may have dramatically different perceptions and interpretations. In a mouse influenza study, the protocol listed "difficult breathing" as the primary criteria to euthanize animals before the planned time point or death. Some staff familiar with the agent may perceive this as openmouth breathing and very close to moribund, while other staff may define it as a more rapid breathing but otherwise normal. Definitions of clinical signs should be unambiguous and clearly understood prior to their inclusion in score sheets and underscore the need for training for observers.
The "score" system does not need to be complex and can be more of a binary function, observed or not observed. This simplifies the scoring to ensure compliance rather than maximize the data from the score sheet. As the research staff uses the sheets, they may continue to refine and reintroduce scales for each observation.
Score sheet can also be used conditionally based on the onset of clinical signs. For example, with some tuberculosis studies, clinical signs may not be present for a year or more, or studies with highly virulent infections can be very short in duration where no clinical signs are expected. However, when or if clinical signs appear, then it is important to institute the score sheet. The frequency of monitoring can also change based on clinical signs. The example provided in Figure 6 indicates that twice daily observations are required and that use of the score sheet becomes mandatory when any animal in the experimental group begins to show signs. The varying needs of the study and welfare of the animals will dictate the best possible configuration of the form.
The information and examples provided here focus on mice, because they are the most commonly used mammalian laboratory animal. However, many references are available that list options for clinical signs in other species, including humans. 98, [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] 
Ethograms
Ethograms are a means of assessing well-being by characterizing species-specific behaviors, recognizing that normal behaviors may be altered when the animals are distressed. There are a number of behaviors that can be evaluated, including general activity, grooming, sleep, postures, social interactions, reproductive behaviors, nesting behavior, and feed and water consumption. 110 Many of these parameters can be incorporated into a score sheet for clinical assessments as described above.
Activity and Appearance
Much information can be gained by observing individual behavior, interactions with cage mates, daily activities, and basic self-preservation. Watching these interactions, or lack thereof, may provide the first indication that an abnormality exists. 97 Mice, like most animals, have decreased activity levels and interactions with cage mates when they are distressed. An abnormal, depressed, or moribund mouse may be less mobile, have Figure 5 . Score sheet for influenza study developed based on a prior pilot study. Note this form tracks individual animals, but for this protocol only requires twice a day monitoring for 5 to 6 days. an unkempt appearance, or decreased coat sheen due to decreased desire or effort to properly groom itself. 97, 111 Decreased or absent grooming can lead to a buildup of ocular secretions around the eyes and nose, such as porphyrin, and excess anal and skin gland secretions, all of which cause a disheveled and unkempt appearance.
In mice, overall appearance is best identified before outside influence such as room entry, cage manipulation, or handling alter behavior. Abnormal behaviors may be masked as mice are a prey species. By the time mice display overt clinical, it is likely that pain or distress may have been overlooked or gone unnoticed. 97 A pain scale based on facial appearances, known as the "mouse grimace scale," was recently developed in mice. The mouse grimace scale rates orbital tightening, nose bulge, cheek bulge, ear position, and whisker change on a 0 to 2 scale, where higher ratings are more indicative of pain. 112, 113 Similar grimace scales have been developed for rats, rabbits, dogs, sheep, and horses. [114] [115] [116] [117] Nest Building Nest building is a common behavior in rodent species. Functions of a nest include thermoregulation, rearing and maternal activity, avoidance of predators, shelter from harsh lighting, and protection from environmental conditions. 118, 119 Nest material is considered part of environmental enrichment, allowing for sensory and motor stimulation. In the laboratory setting, nests may act to shield the mouse from humans and external stimuli as well as aid in thermoregulation by acting as insulation. 119 Nest building is a specific behavior of rodents that may be used as a noninvasive tool to estimate pain, distress, neurological dysfunction, and overall well-being. [119] [120] [121] Decreased nest building is observed in some infections, for example, following hippocampal degeneration caused by prion infection. 122, 123 Reduced nest building is also a nonspecific response to illness. This is demonstrated when a cage change occurs and the mouse is given fresh material for nest building. Jirkof developed a scoring system, 0 to 5, based on how and to what extent nesting material was manipulated 9 hours after placement. 119 Most healthy mice will start to manipulate fresh nesting material in under an hour of its introduction, typically at the end of the dark phase. 119, 121 There have been many modifications to assessing nest-building performance but most have concluded that healthy mice tend to have the most organized nests, whereas postsurgical, painful, or diseased mice have a decreased nest-building activity. [119] [120] [121] 124 Time-to-integrate-to-nest test (TINT) is another noninvasive method to assess well-being in mice. This occurs after a nest has already been established and then an additional piece of nesting material is placed in the cage. The TINT is the time required for a mouse to incorporate this new piece of material into their current nest. 118 Healthy mice are highly motivated and usually integrate new nesting material into their main nest within 10 minutes. 118 The test is more accurate if the initial nest built meets the following criteria for healthy mice: a central nest site, a shredding of at least 80% of the provided material, and a slightly cupped shape of a height less than half of what would be required to cover a mouse. 119, 124 TINT performed after painful surgeries has resulted in a failed attempt to integrate the material. 118 Although not specifically evaluated for use in infectious disease studies, TINT provides an additional means of refinement as it is a noninvasive and rapid screening test that can be readily performed with little training.
Endpoints:
Mice euthanized at 0, 24, and 48 hours post infection, or if moribund/lack righting reflex. Comments:
Date of Aerosol
1 Morn.
Comments:
Eve.
Comments:
2
Morn.
Comments:

Daily:
Behavior check starting 24 hours after aerosol infection, twice a day, at least 8 hours apart. No clinical signs are expected, but if any animal in the group exhibits any, use this sheet. Animals with clinical signs have hydration evaluated, +/-given SQ or IP fluids, and provided gel diet on the cage floor.
Behavior Check:
For each cage check appropriate behavior column, indicate number of animals, if any, found dead or euthanized for health reasons.
Cage #
Ruffled fur/ Hunched
Ruffled fur/ Hunched Figure 6 . Score sheet for short study where clinical signs are not expected. Information on the score sheet specifies when to use the sheet based on clinical signs noted in the animals.
Weight Loss and Food and Water Intake
Food and water intake can be environmental or species dependent, thus it is good to have a baseline from a healthy animal of the specific species or strain being studied to compare to the one under study. 93, 125 Alternatively, baseline observations can be performed on the individual animals to determine their specific, normal weight and food and water intake. Fluid intake may be more challenging in smaller species, such as rodents, since they are typically provided a large volume of water in relation to their daily requirement. While a starting weight of the bottle could be measured, it would not include the loss of water due to jostling of bottle during cage changes. It may be more beneficial to collect urine and test osmolality or specific gravity to determine the concentration of the urine assuming that the kidneys are functioning properly. Fecal production and consistency as well as skin tent can be used to roughly assess hydration. To decrease the subjectivity of skin tent, the time for the skin to return to normal should be timed. A decrease in food and water intake will inevitably lead to a loss in body condition and weight. Animals that have systemic infections can undergo weight loss because of an increase in inflammatory cytokines (TNF, IL-1, and IL-6) that result in elevated leptin, a protein previously demonstrated to cause anorexia. 126 Serum cytokine concentrations may be correlated with weight loss. 127 Cachexia is a common sequelae of anorexia, from which the animal may be unable to recover. 79, 126, 128 Based on previous publications, a commonly used end point is loss of 10% to 20% of its body weight during the course of a study. 129 The following provides an example of integrating behavioral and physiological parameters to monitor disease progression. 95 Mice were implanted subcutaneously with a passive integrated transponder (PIT) tag and inoculated intranasally with B. pseudomallei. Mice were observed, and a clinical scoring system was applied twice daily during the course of infection. The clinical scoring system was based on a scale of 1 to 4 and accounted for activity, nest building, posture, hair coat, and facial grimace. 130 A score of 1 was considered a normal healthy rodent; a score of 2 was mild illness characterized by subtle behavioral changes, mild orbital tightening, a transient hunched posture; a score of 3 was a moderate illness characterized by obvious behavioral changes, decreased activity, prolonged hunched posture, and moderate to marked orbital tightening; and a score of 4 was marked illness or morbidity characterized by nonresponsiveness to stimulation, slow breathing, and sunken or closed eyes. Body weights were recorded twice daily. Body temperature was measured daily using PIT tag recordings and thermal imaging. Mice became clinically ill by the second day postinoculation with an average clinical score of 4 and a marked reduction in body temperature as measured by PIT tags and thermal imaging (Figures 7 and 8 ). This demonstrates that the behavioral findings correlated well with the marked drop in body temperature in this model and provides investigators with a more subjective criteria for assessing well-being (body temperature) compared with the more objective clinical scoring. However, if individuals are properly trained, it also demonstrates that proper clinical observations can provide a timely assessment of distress. In this example, the observations were conducted twice daily, and, given the marked changes within a short time during the daily observation, it would be more prudent to make more frequent observations. Nonetheless, it demonstrates the utility of using a score sheet with components of an ethogram and temperature monitoring to assess disease progression to develop an appropriate endpoint.
Reduction
The ability to reduce the number of animals used in infectious disease models has been substantial given the significant technological advancements in animal research. The most influential of these technologies are telemetry and imaging modalities that allow for longitudinal evaluation of animals over time, thereby reducing the need for euthanasia at specific time points in a study. Telemetry offers the ability to continuously monitor an animal's physiological response over time. Implementing the use of imaging techniques into these type of studies allows for a significant reduction in animal numbers in cases where the disease pathology could be followed by imaging at multiple time points in the same animals vs euthanizing at those time points to collect tissues. In some cases, end points may also be adjusted to earlier in the disease process because pathology is monitored in real time permitting for greater precision of the model, a valuable refinement in animal use. 131 Telemetry Telemetric monitoring enables researchers to reduce the number of animals used in studies that rely on larger cohorts of animals, varying degrees of monitoring, and moribund or fatal endpoints. 7 It is generally defined as the uninhibited capture and transmission of data to remote locations with computed reception to enable analysis of physiological biomarkers. 132 It has been used by biomedical researchers for over a century and has progressively improved in transmission capabilities, biocompatibility, parameters measured, size, functional lifespan, and ease of implantation. [133] [134] [135] A concise historical review of radiotelemetry use in small laboratory animals has been published. 132 Telemetry can capture a variety of physiologic parameters, longitudinally, in real-time, in unrestrained, conscious animals, depending on the device used. These may include body temperature, heart rate, blood pressure, respiratory rate, and locomotor activity. In addition, biopotential signals such as electrocardiogram, electroencephalogram, and electromyogram can be monitored as required by investigators following challenge. Telemetric monitoring relies on placement of a transponder capable of collecting desired physiologic parameters then transmitting that data to a receiver for subsequent analysis. Data may be obtained noninvasively via external or surface electrodes or through the use of implanted interrogation probes and leads. The frequency of data transmissions can be continuous or intermittent, either at predetermined intervals or as programmed by the investigator. Baseline data collection for study purposes may then be initiated once animals have healed from surgery. 136, 137 Other benefits include noninvasive monitoring during periods of acclimation to gather baseline data as well as activity monitoring during the seldom visualized dark phase, the time at which rodents are the most active. 138 In addition, telemetry allows accurate data collection while reducing animal stress. Brief physical handling, restraint, and rectal probe placement to permit the identification of body temperature has been shown to cause transient iatrogenic elevations in body temperature that may not reflect the true clinical condition of infected animals. 93, [139] [140] [141] Telemetry was used in a Lassa virus surrogate hamster model to identify postchallenge alterations, including a disruption of the normal diurnal temperature pattern and elevated body temperature not easily and accurately captured through nontelemetric methods. 142 Refinement and reduction is especially pronounced when the collection of large amounts of physiological data allows for the construction of humane and informative end points in pathogen-induced models of infectious disease. Remote transmission of data with telemetry can be particularly advantageous in studies requiring high containment (animal biosafety level 3 or 4) where multiple animals can be monitored continuously and simultaneously throughout acclimation, challenge, and progression of disease from a relatively convenient location outside of containment. 136, 137, 142 Depending upon the parameters selected, telemetric monitoring can significantly reduce the number of personnel entries into containment by augmenting the evaluation of animal health through direct observation and minimize the need to handle and disturb cages. Repeated containment entries can be a source of significant financial cost, and direct manipulation of infected animals for collection of data carries some risk to the handler and stress to the animal. 143 Despite these benefits, it is important to note that although parameters may be identified through telemetric monitoring, each pathogen-induced model exhibits an individual fingerprint of physiological alterations in regards to measurable markers such as time to onset of febrile state and development of terminal hypothermia. 142, 144 Thus, each model must be evaluated individually, especially when considering the identification and implementation of humane end points. In fact, routine temperature evaluation has been suggested as a mandatory requirement for monitoring infectious disease studies. 79 Trammell and Toth asked retrospectively if temperature alone or temperature and body weight (T × BW) together could effectively identify humane end points in several mouse models of infectious disease. 145 In some cases, such as DBA/2J mice inoculated with C. albicans, temperature and T × BW could be used to identify if mice would live or die. In contrast, these same parameters were found to not be accurate predictors when normal C57BL/6J mice were given the same pathogen. In conclusion, Trammell and Toth found that the application of these end points was dependent upon mouse strain and pathogen interaction, highlighting the requirement for model-specific end points.
Precise monitoring of physiologic parameters permits the implementation of investigational therapeutic strategies or humane euthanasia. Investigators have recently refined a murine cecal ligation and puncture model of sepsis with telemetry by identifying the point of physiologic deterioration by evaluating heart rate, core temperature, and mobility. Independent host response varies, and telemetry allows researchers to include animals at the exact physiologic parameters needed to recapitulate human enrollment criteria rather than relying on predetermined time points. This produces a more uniform group of experimental animals, effectively reducing variability and allowing for appropriate and precise intervention through investigational therapies or timely euthanasia. An added benefit is that the researcher may immediately collect blood and tissues, preventing degradation and loss of data that may occur if impending death is not recognized. Importantly, it also prevents the inclusion of animals that would exhibit spontaneous recovery, regardless of therapeutic intervention. 146 Telemetric monitoring requires a significant financial investment in implantable transponders, data acquisition systems, and software. Surgical implantation of transponders and associated leads can be technically demanding and postsurgical complications may arise. The applicability of a given transponder can be greatly influenced by the physical size of the device and may preclude implantation in certain anatomic locations, especially in rodents. The batteries powering transponders have a defined lifespan and occasionally malfunction, causing decreased functional capability and limiting the value of collected data. Although uncommon, the loss of transponder functionality postchallenge effectively removes the implanted animal from the current study. Transponders are frequently single-use rather than repeatedly sterilized for this reason. Despite these apparent drawbacks, the investment of telemetry early can be offset over time through the reduction in animal numbers, a finding exhibited in a sepsis model but likely in alignment with many infectious disease models. 147 Overall, telemetry allows the potential to collect a tremendous amount of clinically relevant data that can inform study design, implement refined end points, and reduce the number of animals required to conduct rodent infectious disease studies.
Imaging
The use of advanced imaging techniques has played an integral part in reducing the number of animals used on projects, and they are increasingly being used to image in vivo disease processes in animals, including infectious disease research models. Infectious disease research invariably requires examining the pathogenesis and distribution of the agent in live systems, and historically this equates to euthanasia of the animals at multiple time points to collect and analyze tissues. This not only leads to a greater number of animals being needed, but it also requires that the disease process is allowed to progress to severe or terminal disease in some animals, which increases the animals' pain and distress. Instead, noninvasive imaging modalities can be used to track disease progression over time.
A wide array of imaging modalities are being used for infectious disease studies, including positron emission tomography (PET), computerized tomography (CT), magnetic resonance imaging (MRI), and optical imaging, that benefit researchers and reduce the number of animals used. 131, 148, 149 PET is a molecular imaging technique widely used in clinical human and animal medicine to visualize a variety of in vivo biological processes, most commonly neoplastic diseases. Positronemitting radiotracers are administered, and then the machine detects these emissions and produces 3-dimensional images of their locations within the body. Various radiotracers are used based on the tissue or cell type to be detected. 2-deoxy-2-[ 18 F] fluoro-D-glucose (FDG) is the most routinely used for cancer studies because malignant cells have an increased uptake of glucose and the radiotracer will concentrate in neoplastic tissues. However, all metabolically active cells will uptake glucose, so this tracer is also useful when tracking cells such as macrophages, neutrophils, and lymphocytes present in infectious disease processes. [149] [150] [151] Other radiotracers targeting specific tissues or cells are being developed, which will allow greater specificity in tracking infectious disease processes. For example, Zika virus has been imaged in mice using [ 18 F]DPA-714, which targets a translocator protein that is highly upregulated in central nervous system-activated microglia, reactive astrocytes, and multiple leukocytes. 152 [ 18 F]FDG PET was used to study cerebral malaria in nonhuman primates and demonstrated decreased cerebral metabolic activity. 149 64 Cu-diethylene-triaminepentaacetic acid was administered to mice infected with F. tularensis via various routes, and PET imaging demonstrated the rapid dissemination to multiple tissues with different trafficking patterns depending on route of infection. 149 CT uses sectional x-ray imaging to develop a 3-dimensional image of the anatomy of interest. 150 Attenuation of the x-rays by the various tissue types in the body allows for differentiation and identification of the structures, both normal and abnormal. The administration of contrast agents to the animal increases the visualization of soft tissues and can also have additional molecules added that will attach to specific cells, such as those found in infectious and inflammatory conditions. Influenza virus in ferrets has been imaged via CT based on studies showing that a pulmonary ground-glass opacity corresponds to areas of alveolar edema, which is a major histological lesion early in disease. 153 MicroCT equipment is now available for small animal imaging, which allows for decreased expense and smaller space requirements. 150 MRI uses a strong magnet and radiofrequency energy to detect atomic nuclei polarization in the body to develop an image of internal soft tissue structures. 150 Although MRI has an extremely weak signal and poor sensitivity, this can be overcome by the administering contrast agents such as 1 H, 31 P, 13 C, 17 O 2 , gadolinium, or iron-based agents. 149, 150 Various techniques for administering the magnetic waves have also been developed to image different tissues, including dynamiccontrast MRI, diffusion-weighted MRI, and blood oxygen leveldependent MRI. 150 MRI has been used to image the disease pathologies associated with Chagas disease, human African trypanosomiasis, malaria, tuberculosis, schistosomiasis, and HIV-1 in various animal models. 149 For example, a macaque infected with simian/human immunodeficiency virus that presented with HIV-associated dementia was imaged via MRI and demonstrated enhanced signaling in multiple areas of the brain, as well as ventricular dilation and asymmetric atrophy, with procession to death of the animal in a short time frame, demonstrating that MRI may be useful in the early diagnosis of HIV-associated dementia. 154 CT and MRI are often combined with PET to visualize direct comparison of the anatomical and the functional findings, overlapping the PET image on top of the anatomical image (CT or MRI). 155, 156 Influenza in ferrets was imaged using PET-CT and demonstrated spatiotemporal progression of the inflammation in real time. 157 PET-CT was utilized in M. tuberculosis-infected macaques to track treatment responses by pulmonary lesion size and to determine that latent infections could be predicted to develop reactivation based on granuloma number, size, or FDG uptake. 151, 158 Optical imaging is a broad term used to describe the detection of visible light that arises from either the excitation of a fluorescent protein/molecule or from an enzyme-catalyzed oxidation reaction known as bioluminescence. 131 Special cameras using sensitive photon detectors within cooled, intensified, charge-coupled devices are able to quantify the spatial and temporal distribution of light within the tissues to track cells, tissues, or organisms labelled with the light-emitting molecule. 131, 159 For bioluminescent imaging (BLI), several naturally occurring luciferases have been cloned and produced for regular use, including firefly, jellyfish, sea pansy, and Vibrio and Photorhabdus bacteria luciferases. 148, 159 More recently, clickbeetle luciferase was developed to image Listeria monocytogenes in murine infection models. 160 The luciferase reporters are inserted into the infectious organism's genome, and the animal model is infected with the tagged organism. These natural luciferase systems (Lux-enzymes) require energy, oxygen, and a substrate (luciferin), which is administered to the animal prior to imaging. 159, 160 Luc-systems are an alternative to administering exogenous luciferin using the bioluminescent bacteria Photorhabdus or Xenorhabdus, which encodes genes to produce luciferase and luciferin. 148 In these ways, the disease progression can be tracked via the optical imaging device.
BLI has been used to study a wide array of infectious diseases including Salmonella typhimurium, P. aeruginosa, Y. pestis, Staphylococcus aureus, HSV-1, poxviruses, and many more. 131, 148, 161 Although pathogenesis and disease trafficking are the most common uses for the BLI imaging, it is also being used to monitor for the effectiveness of therapeutics and preventatives. In one study, a DNA vaccine for Chikungunya virus was evaluated by creating a pseudovirus system expressing the firefly luciferase reporter protein (pHIV-CHIKV-Fluc) and showed promising protective effects of the vaccine tested. 162 Fluorescent imaging is accomplished by utilizing molecular probes with a fluorescent reporter group. Near-infrared dyes with emission wavelengths of 650 to 900 nm are often used because they can emit through ≥2 cm of tissue. 150, 163, 164 The dyed probes are developed to target specific tissue or cell types and are then injected into the animal prior to imaging to track those cells, for example, inflammatory, apoptotic, or bacterial cells. 163, 164 An alternative to injection of dyes is the integration of a fluorescent protein molecule into the cell or gene of interest. Green fluorescent protein (GFP) is one of the most well-known of these, with red fluorescent protein also commonly used, although there are a multitude of others now available for specific imaging functions. 150 Fluorescent molecular tomography is a progression of this methodology that allows for 3-dimensional reconstitution of the fluorescent accumulation in the tissues leading to quantification of the processes taking place. 150 Fluorescent imaging has been used to track Schistosomiasis parasitic burdens and S. aureus endocarditis and muscle infections in mice. 149, 163, 164 A GFP-tagged Influenza virus studied in mice allowed for imaging of both viral and immune cell tracking, then was compared to the progression of the disease after viral inhibitor treatments. 165 A double transfected (bioluminescent and fluorescent tagged), virulent Leishmania donovani organism was developed to noninvasively perform a longitudinal study of this parasitic disease process in mice. 166 Although BLI appears to be the most prevalent in the literature, most of the imaging equipment that utilizes BLI can image fluorescent proteins and many also include digital radiography co-registration to provide an anatomical overlay, therefore greatly increasing the flexibility and range of use for this type of imaging. 131 Dual labelling of microorganisms is becoming more popular, for example, tagging an organism with luciferase in tandem with GFP, which allows for both counting of organisms via fluorescence and metabolic activity quantification via bioluminescence. 131 The benefits of these modalities on research and animal use are apparent; however, the special circumstances surrounding working in biohazardous environments must be taken into consideration when deciding to implement their use in projects. Facility space, environmental containment, and ability to sanitize or sterilize the equipment after use and between experiments must be carefully planned. Many high containment facilities are solving these issues in novel and inventive ways and are publishing their outcomes, which will allow others to more easily implement these imaging modalities in their projects. [167] [168] [169] [170] [171] [172] [173] [174] [175] Conclusion Replacement, reduction, and refinement are basic premises of using animals in research, but the unique needs of studying biohazardous agents in animal models can lead to difficulties in applying these principles. Animals that may become acutely sick from bacterial or viral infections show nonspecific clinical signs that most reliably include: changes in body temperature, decreased grooming, appearance changes, loss of interest for daily activities, reduction in food intake, and decreased socialization. This poses challenges in applying the 3Rs as inducing distress is required for the project to mimic the disease process and clinical symptoms of the disease. 176 While application of the 3Rs may be challenging, there are advancements that make it feasible, and here we summarized many applications in infectious disease research. Most would agree that death as an end point in infectious disease studies is not acceptable. Applying the 3Rs to infectious disease work to reduce the distress animals incur during these studies not only improves animal welfare, it also enhances the science. In vitro model systems provide opportunities to assess cellular interactions using cell culture models, and more advance interactions can be performed with engineered multi-tissue model systems.
Simple model systems such as C. elegans and Drosophila have been verified in vertebrate model systems as they possess similar cellular biology, including innate immune responses that can be used as replacements to vertebrate animal models. D. discoideum, C. elegans, and Drosophila are intriguing models because they offer the ability for high-throughput screening of virulence factors and pathogen-host interactions using genetically modified hosts. Score sheets, when properly developed and applied, provide an excellent tool for refining animal use. Evaluation of behaviors, activity, facial grimace, body temperature, food and water intake, and nest building can offer valuable insight into the disease progression and can readily be incorporated into scoring systems. Monitoring these parameters can aide in early end point determination before significant clinical illness is present. While there are challenges to using these parameters, they have been used successfully in specific models and can be applied to other models. Advancements in technology have helped to reduce the number of animals used in infectious disease studies. Telemetry and imaging modalities allow the continuous and longitudinal assessment of animals over the course of disease. This allows assessment of a single animal over time, which was previously done by euthanizing cohorts at various time points during disease. While there is no single method available to universally apply to all infectious disease models, several techniques to replace, refine, and reduce the number of animals used in infectious disease research are available and should be considered when developing animal models.
